Skip to Content
Skip to Sidebar
Skip to Navigation
Akesis Pharmaceuticals
Home
About Us
Fast Facts
Management
Board of Directors
Scientific Advisory Board
Pipeline
The Diabetes Epidemic
Intellectual Property
Investor Relations
Stock Information
Akesis Team
Press Releases
SEC Filings
Contact Us
Contact Us
Legal Information
MDB Capital Group LLC- Akesis Initiation Report
Jul 7, 2008
Organic vanadium, an insulin sensitizer targeting PTP-1b and other pathways